{"id":1676,"date":"2023-06-25T17:29:32","date_gmt":"2023-06-25T17:29:32","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/bisoprolol-fumarate\/"},"modified":"2023-06-25T19:47:09","modified_gmt":"2023-06-25T19:47:09","slug":"bisoprolol-fumarate","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/bisoprolol-fumarate\/","title":{"rendered":"Bisoprolol fumarate"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Bisoprolol fumarate.JPG\"><\/p>\n<h1>Bisoprolol fumarate<\/h1>\n<h3>  CLINICAL USE<\/h3>\n<p>Beta-1 adrenoceptor blocker:cinHypertension, angina<\/p>\n<li>Adjunctive treatment for heart failure<br \/>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<p>5\u201320 mg dailyHeart failure: 1.25 mg daily increasing to 10 mg daily<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<\/li>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :767<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :30<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; : 50<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; :3.5<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; :9\u201312\/18\u201324<br \/>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<\/li>\n<li> 20 to 50  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> 10 to 20  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : Dose as in normal renal function<br \/>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:Not dialysed. Dose as in normal renal function<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :Not dialysed. Dose as in normal renal function<\/li>\n<li>HDF\/high flux  &nbsp; :Unknown dialysability. Dose as in normal renal function<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;:Unknown dialysability. Dose as in normal renal function<br \/>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<\/li>\n<li>Anaesthetics: enhanced hypotensive effect<\/li>\n<li>Analgesics: NSAIDs antagonise  hypotensive effect<\/li>\n<li>Anti-arrhythmics: increased risk of  myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodarone<\/li>\n<li>Antibacterials: concentration reduced by  rifampicin<\/li>\n<li>Antidepressants: enhanced hypotensive  effect with MAOIs<\/li>\n<li>Antihypertensives: enhanced hypotensive  effect; increased risk of withdrawal hypertension with clonidine; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosin<\/li>\n<li>Antimalarials: increased risk of  bradycardia with mefloquine<\/li>\n<li>Antipsychotics: enhanced hypotensive  effect with phenothiazines<\/li>\n<li>Calcium-channel blockers: increased  risk of bradycardia and AV block with diltiazem; hypotension and heart failure possible with nifedipine and nisoldipine; asystole, severe hypotension and heart failure with verapamil<\/li>\n<li>Diuretics: enhanced hypotensive effect Moxisylyte: possible severe postural  hypotension<\/li>\n<li>Sympathomimetics: severe hypertension  with adrenaline and noradrenaline, and possibly with dobutamine<br \/>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>\u2013<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<p>Use with caution in patients with chronic  obstructive airways disease, asthma or diabetes<\/li>\n","protected":false},"excerpt":{"rendered":"<p>Bisoprolol fumarate CLINICAL USE Beta-1 adrenoceptor blocker:cinHypertension, angina Adjunctive treatment<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-1676","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=1676"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1676\/revisions"}],"predecessor-version":[{"id":2868,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1676\/revisions\/2868"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=1676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=1676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=1676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}